Literature DB >> 9081121

Natural history and management of the asymptomatic, moderately stenotic internal carotid artery.

C B Rockman1, T S Riles, P J Lamparello, G Giangola, M A Adelman, D Stone, C Guareschi, J Goldstein, R Landis.   

Abstract

PURPOSE: Although it has been widely accepted as the evidence supporting prophylactic carotid endarterectomy, aspects of the Asymptomatic Carotid Atherosclerosis Study have left unease among clinicians who must decide which individuals without symptoms should undergo surgery. Additional confusion has been created by the fact that the several large randomized trials investigating the efficacy of carotid endarterectomy have classified and analyzed different categories of carotid stenosis. In an effort to provide more information on the natural history of asymptomatic, moderate carotid artery stenosis (50% to 79%), we have reviewed data on approximately 500 arteries.
METHODS: Records of our vascular laboratory from 1990 to 1992 were reviewed. We identified 425 patients with asymptomatic, moderate carotid artery stenosis; 71 patients had bilateral stenoses in this category, resulting in 496 arteries for study.
RESULTS: The mean length of follow-up was 38 +/- 18 months. New ipsilateral strokes occurred in 16 (3.8%) patients. New ipsilateral transient ischemic attacks occurred in 25 (5.9%) patients. Documented progression of stenosis occurred in 48 (17%) of the 282 arteries for which a repeat duplex examination was available. Arteries that progressed to > 80% stenosis were significantly more likely to have caused strokes than those that remained in the 50% to 79% range (10.4% vs 2.1%, p < 0.02). Conversely, arteries that remained stable in the degree of stenosis were significantly more likely to have remained asymptomatic than those that progressed (92.7% vs 62.5%, p < 0.001). With life-table analysis the estimated cumulative ipsilateral stroke rate was 0.85% at 1 year, 3.6% at 3 years, and 5.4% at 5 years. The respective estimated cumulative transient ischemic attack rates were 1.9%, 5.5%, and 6.3%. The respective estimated cumulative rates for progression of stenosis were 4.9%, 16.7%, and 26.5%. Life-table comparison of ipsilateral stroke revealed a significantly higher cumulative rate among arteries that progressed in the degree of stenosis than among those that remained stable (p < 0.001).
CONCLUSIONS: Based on the low rate of permanent neurologic events in these cases, prophylactic carotid endarterectomy for the asymptomatic, moderately stenotic internal carotid artery cannot currently be recommended. The only factor that appears to predict increased risk for future stroke is progression of stenosis. Careful follow-up with serial repeat duplex examinations must be performed in these patients. Until there are widely accepted duplex parameters that can provide all clinicians with accurate identification of arteries with narrowing corresponding to 60% stenosis as defined by the Asymptomatic Carotid Atherosclerosis Study, all surgeons will need to be aware of specifically how their noninvasive laboratories are deriving their results. For the many laboratories that continue to use the University of Washington criteria, 80% should remain the level above which prophylactic carotid endarterectomy is warranted.

Entities:  

Mesh:

Year:  1997        PMID: 9081121     DOI: 10.1016/s0741-5214(97)70250-7

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  9 in total

Review 1.  Treatment of atherosclerotic disease at the cervical carotid bifurcation: current status and review of the literature.

Authors:  J J Connors; D Seidenwurm; J C Wojak; R W Hurst; M E Jensen; R Wallace; T Tomsick; J Barr; C Kerber; E Russell; G M Nesbit; A J Fox; F Y Tsai
Journal:  AJNR Am J Neuroradiol       Date:  2000-03       Impact factor: 3.825

2.  Quality improvement guidelines for the performance of cervical carotid angioplasty and stent placement.

Authors:  John D Barr; John J Connors; David Sacks; Joan C Wojak; Gary J Becker; John F Cardella; Bohdan Chopko; Jacques E Dion; Allan J Fox; Randall T Higashida; Robert W Hurst; Curtis A Lewis; Terence A S Matalon; Gary M Nesbit; J Arliss Pollock; Eric J Russell; David J Seidenwurm; Robert C Wallace
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

3.  Carotid Webs: Radiographic Appearance and Significance.

Authors:  Kyle Wojcik; James Milburn; Gabriel Vidal; Andrew Steven
Journal:  Ochsner J       Date:  2018

4.  Cilostazol prevents progression of asymptomatic carotid artery stenosis in patients with contralateral carotid artery stenting.

Authors:  T Kato; H Sakai; T Takagi; Y Nishimura
Journal:  AJNR Am J Neuroradiol       Date:  2012-02-09       Impact factor: 3.825

5.  [Carotid artery screening for stroke prevention].

Authors:  C Arning
Journal:  Radiologe       Date:  2013-09       Impact factor: 0.635

6.  Natural history of > or =60% asymptomatic carotid stenosis in patients with contralateral carotid occlusion.

Authors:  Ali F AbuRahma; Matthew J Metz; Patrick A Robinson
Journal:  Ann Surg       Date:  2003-10       Impact factor: 12.969

Review 7.  Carotid revascularization: risks and benefits.

Authors:  Marlene O'Brien; Ankur Chandra
Journal:  Vasc Health Risk Manag       Date:  2014-07-07

Review 8.  Neuroimaging of the vulnerable plaque.

Authors:  Karl-Olof Lovblad; Vitor Mendes-Pereira; Valentina Garibotto; Frederic Assal; Jean-Pierre Willi; Roman Stztajzel; Osman Ratib; Maria Isabel Vargas
Journal:  Curr Vasc Pharmacol       Date:  2015       Impact factor: 2.719

9.  Survey of Current Management Practices for Carotid Webs.

Authors:  Kyle Wojcik; James Milburn; Gabriel Vidal; Joseph Tarsia; Andrew Steven
Journal:  Ochsner J       Date:  2019
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.